OBIO — Early Adopter Health Network (EAHN)
At a glance
- No Condition
- Open Date : August 01, 2022
- All industries
- Ontario Bioscience Innovation Organization
Overview
Eligibility criteria
The OBIO EAHN grant program aims to support Canadian health technology companies and healthcare organizations in evaluating and adopting innovative technologies. Financial support is available for companies and healthcare organizations during the evaluation process.
- Canadian health technology companies looking to evaluate and adopt innovative technologies are eligible.
- Healthcare organizations interested in partnering with technology companies to improve patient care and efficiency are eligible.
- Financial support is available for companies and healthcare organizations during the evaluation process.
Who is eligible
There are eligible types of companies for this grant. The grant supports Canadian health technology companies that are looking to evaluate their technologies in a real-world setting and facilitate their adoption into the health system.
- Innovative Canadian health technology companies
Eligible expenses
There are eligible expenses for this grant. Companies and healthcare organizations participating in the EAHN™ program can receive financial support for the evaluation process. Eligible expenses include:
- Technology evaluation costs
- Implementation support
- Training expenses
- Data collection and analysis
- Any other related expenses approved by OBIO®
Eligible projects & activities
There are activities eligible for this grant. The OBIO® EAHN™ program supports Canadian health technology companies and healthcare organizations in evaluating technologies, facilitating their adoption into the health system, and providing financial support during the evaluation.
- Evaluation and adoption of innovative healthcare technologies
- Collaboration between health technology companies and healthcare organizations
- Financial support for technology evaluation
- Facilitation of technology adoption into the health system
Evaluation & selection criteria
The OBIO's Early Adopter Health Network (EAHN™) program has evaluation and selection criteria for companies seeking financial support:
- Demonstrated potential to improve patient care, provider satisfaction, and system efficiency.
- Evidence of innovation and value-producing technologies.
- Strong interest in advancing Canadian healthcare solutions.
How to apply
- Visit the OBIO website to access the grant application form.
- Review the eligibility criteria and ensure your company meets all requirements.
- Complete the application form with accurate and detailed information about your health technology innovation.
- Submit the application before the specified deadline to be considered for the grant.
Grant Summary:
This grant program, the Early Adopter Health Network (EAHN™), supports Canadian health technology companies and healthcare organizations in evaluating and adopting innovative technologies to enhance patient care and optimize system efficiency.
Grant Details:
The OBIO Early Adopter Health Network (EAHN™) program is designed to bridge the gap between health technology companies and healthcare organizations by facilitating the evaluation and adoption of cutting-edge healthcare solutions in real-world settings. Through this program, Canadian companies can partner with a national network of healthcare providers to showcase their technologies, gain valuable feedback, and receive financial support for the evaluation process. EAHN™ aims to accelerate the adoption of innovative technologies that improve patient outcomes, drive system efficiency, and position Canadian companies for global success.
Participating companies have the opportunity to collaborate with leading healthcare organizations such as the University Health Network, Synaptive Medical, Southlake Regional Health Centre, and Huron Digital, among others. These partnerships enable companies to refine their products, access Canadian markets, and enhance their global value proposition. The program also supports companies in making final technology enhancements based on evaluation outcomes, fostering local adoption champions, and facilitating access to the global marketplace.
Healthcare organizations involved in the EAHN™ program benefit from pre-vetted Canadian technologies that are commercially ready, allowing them to focus on value-based analysis for future procurement decisions. The program serves as a platform for healthcare providers to engage with innovators, improve patient care, enhance provider satisfaction, and contribute to system-wide efficiency. By participating in EAHN™ evaluations, healthcare organizations play a vital role in advancing leading-edge Canadian technologies and showcasing successful innovations to a global audience.
In addition to fostering industry-driven partnerships, EAHN™ collaborates with national and regional innovation partners in the health sciences ecosystem to provide resources, adoption strategies, and program support to companies and healthcare partners. The program's success is evidenced by testimonials from CEOs and executives who recognize EAHN™ as a catalyzing force for financing rounds and technology advancements in their respective markets.
Overall, the OBIO Early Adopter Health Network (EAHN™) program plays a vital role in connecting Canadian health technology companies with healthcare organizations to drive innovation, improve patient outcomes, and establish Canada as a global leader in healthcare technology adoption and commercialization.
